Next Article in Journal
Biodiversity of Actinobacteria from the South Pacific and the Assessment of Streptomyces Chemical Diversity with Metabolic Profiling
Next Article in Special Issue
Bacillibactin and Bacillomycin Analogues with Cytotoxicities against Human Cancer Cell Lines from Marine Bacillus sp. PKU-MA00093 and PKU-MA00092
Previous Article in Journal
Construction of a Fluorescent H2O2 Biosensor with Chitosan 6-OH Immobilized β-Cyclodextrin Derivatives
Previous Article in Special Issue
Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Biogenetic Relationships of Bioactive Sponge Merotriterpenoids

by
Thomas E. Smith
1,2
1
Department of Medicinal Chemistry, University of Utah, 30 S. 2000 E., Salt Lake City, UT 84112, USA
2
Department of Integrative Biology, University of Texas at Austin, 2506 Speedway, NMS 4.216 stop C0930, Austin, TX 78712, USA
Mar. Drugs 2017, 15(9), 285; https://doi.org/10.3390/md15090285
Submission received: 25 July 2017 / Revised: 7 September 2017 / Accepted: 7 September 2017 / Published: 10 September 2017
(This article belongs to the Special Issue Genome Mining and Marine Microbial Natural Products)

Abstract

Hydroquinone meroterpenoids, especially those derived from marine sponges, display a wide range of biological activities. However, use of these compounds is limited by their inaccessibility; there is no sustainable supply of these compounds. Furthermore, our knowledge of their metabolic origin remains completely unstudied. In this review, an in depth structural analysis of sponge merotriterpenoids, including the adociasulfate family of kinesin motor protein inhibitors, provides insight into their biosynthesis. Several key structural features provide clues to the relationships between compounds. All adociasulfates appear to be derived from only four different hydroquinone hexaprenyl diphosphate precursors, each varying in the number and position of epoxidations. Proton-initiated cyclization of these precursors can lead to all carbon skeletons observed amongst sponge merotriterpenoids. Consideration of the enzymes involved in the proposed biosynthetic route suggests a bacterial source, and a hypothetical gene cluster was constructed that may facilitate discovery of the authentic pathway from the sponge metagenome. A similar rationale can be extended to other sponge meroterpenoids, for which no biosynthetic pathways have yet been identified.
Keywords: sponge; meroterpenoid; marine natural product; medicinal chemistry; biosynthesis; drug discovery sponge; meroterpenoid; marine natural product; medicinal chemistry; biosynthesis; drug discovery

Share and Cite

MDPI and ACS Style

Smith, T.E. Biogenetic Relationships of Bioactive Sponge Merotriterpenoids. Mar. Drugs 2017, 15, 285. https://doi.org/10.3390/md15090285

AMA Style

Smith TE. Biogenetic Relationships of Bioactive Sponge Merotriterpenoids. Marine Drugs. 2017; 15(9):285. https://doi.org/10.3390/md15090285

Chicago/Turabian Style

Smith, Thomas E. 2017. "Biogenetic Relationships of Bioactive Sponge Merotriterpenoids" Marine Drugs 15, no. 9: 285. https://doi.org/10.3390/md15090285

APA Style

Smith, T. E. (2017). Biogenetic Relationships of Bioactive Sponge Merotriterpenoids. Marine Drugs, 15(9), 285. https://doi.org/10.3390/md15090285

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop